Bridging the Gap: How Early De-Risking Supports Manufacturing
1:30 pm - Thursday 17th September 2026
- How early developability and manufacturability assessments can identify risks before a molecule enters process development
- The value of generating representative non-GMP material early to answer critical productivity, product quality, and manufacturability questions while accelerating downstream activities
- How an integrated approach spanning discovery through manufacturing enables better decision-making, proactive risk mitigation, and smoother progression of complex biologics, including bispecifics
